Search

Your search keyword '"López Montesinos, Inmaculada"' showing total 38 results

Search Constraints

Start Over You searched for: Author "López Montesinos, Inmaculada" Remove constraint Author: "López Montesinos, Inmaculada"
38 results on '"López Montesinos, Inmaculada"'

Search Results

3. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

4. Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

5. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

6. Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant Pseudomonas aeruginosa

8. Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae

9. Antibiotic desensitization as a potential tool in antimicrobial stewardship programs: retrospective data analysis and systematic literature review

11. Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates

13. Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

14. Application of an adaptable multimodal machine learning approach to predict COVID-19 outcomes for hospital resource management

15. Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption

16. Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality

17. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality

18. Severe Hypoalbuminemia at Admission Is Strongly Associated with Worse Prognosis in Older Adults with SARS-CoV-2 Infection

19. Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality

20. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates

21. Prevalence and Prognostic Value of Myocardial Injury in the Initial Presentation of SARS-CoV-2 Infection among Older Adults

22. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

23. COVID19 Outcome Prediction: Differences Between Raw Laboratory and Human Pre-Processed Data

24. Impact of a Nosocomial COVID-19 Outbreak on a Non-COVID-19 Nephrology Ward during the First Wave of the Pandemic in Spain

25. Severe hypoalbuminemia at admission is strongly associated with worse prognosis in older adults with sars-cov-2 infection

26. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis

27. Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection

28. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

29. Low zinc levels at clinical admission associates with poor outcomes in COVID-19

30. Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?

31. Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections : what is the Influence of XDR Phenotype on Outcomes?

32. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality.

33. Oral and intravenous fosfomycin in complicated urinary tract infections

34. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis

35. Ceftolozane-tazobactam: When, how and why using it?

36. Oral and intravenous fosfomycin in complicated urinary tract infections.

37. Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

38. Comparison of Hospitalized Coronavirus Disease 2019 and Influenza Patients Requiring Supplemental Oxygen in a Cohort Study: Clinical Impact and Resource Consumption.

Catalog

Books, media, physical & digital resources